protein

Kanamycin kinase type II/NEO protein, Klebsiella pneumoniae

HY-P70228

10 μg;50 μg

120;360 USD

Kanamycin kinase type II/NEO protein, Klebsiella pneumoniae

proteins

E. coli

10 μg;50 μg

120;360 USD

The Kanamycin kinase type II/NEO protein imparts resistance to aminoglycoside antibiotics, including kanamycin, neomycin, paromomycin, ribostamycin, butirosin, and gentamicin B. It counteracts their inhibitory effects, showcasing the protein's versatility in mitigating the impact of various antibiotics and enabling the organism to thrive in their presence. Kanamycin kinase type II/NEO protein, Klebsiella pneumoniae is the recombinant Kanamycin kinase type II/NEO protein, expressed by E. coli , with tag free. The total length of Kanamycin kinase type II/NEO protein, Klebsiella pneumoniae is 264 a.a., with molecular weight of 26-30 kDa.

Others

The Kanamycin kinase type II/NEO protein confers resistance to a spectrum of aminoglycoside antibiotics, including kanamycin, neomycin, paromomycin, ribostamycin, butirosin, and gentamicin B. Its role involves mitigating the impact of these antibiotics, allowing the organism to withstand their inhibitory effects. This resistance mechanism highlights the versatility of the Kanamycin kinase type II/NEO protein, as it counteracts multiple members of the aminoglycoside antibiotic class, contributing to the organism's ability to thrive in the presence of these antimicrobial agents.

rKlAminoglycoside 3'-phosphotransferase; Aminoglycoside 3'-phosphotransferase; APH(3')-II; APH(3')II; Kanamycin kinase type II; Neomycin-kanamycin phosphotransferase type II; neo

Greater than 95% as determined by reducing SDS-PAGE.

Supplied as a 0.2 μm filtered solution of 20 mM Tris-HCl, 6%Trehalose, 4%Mannitol, 0.05%Tween80, pH 8.0.

Shipping with dry ice